OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Cancer is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Cancer statistics for the year 2020: An overview	2548
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE‐158 and KEYNOTE‐028 studies	296
A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale	220
Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050	158
Liquid biopsies: Potential and challenges	142
Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities	110
Novel insights into the function of CD24: A driving force in cancer	108
Cancer associates with risk and severe events of COVID‐19: A systematic review and meta‐analysis	97
Lipocalin 2 expression promotes tumor progression and therapy resistance by inhibiting ferroptosis in colorectal cancer	92
The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction	91
The role of CDK6 in cancer	91
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020	91
Relationship between MLH1, PMS2, MSH2 and MSH6 gene‐specific alterations and tumor mutational burden in 1057 microsatellite instability‐high solid tumors	88
Caspase‐8: A key protein of cross‐talk signal way in “PANoptosis” in cancer	84
Is it possible to halve the incidence of liver cancer in China by 2050?	84
Profiling global cancer incidence and mortality by socioeconomic development	80
The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha‐fetoprotein	78
Incidence of childhood renal tumours: An international population‐based study	78
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies	75
Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization	74
Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039	67
Predicted long‐term impact of COVID‐19 pandemic‐related care delays on cancer mortality in Canada	65
Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC‐ESCC2019): A multicenter, phase 2 study	65
Thyroid cancer, recent advances in diagnosis and therapy	59
Methylation markers FAM19A4 and miR124‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study	58

The “unnatural” history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance	57
Cancer in Iran 2008 to 2025: Recent incidence trends and short‐term predictions of the future burden	56
Dysbiosis of the endometrial microbiota and its association with inflammatory cytokines in endometrial cancer	55
Drugging “undruggable” genes for cancer treatment: Are we making progress?	53
The role of SIRT2 in cancer: A novel therapeutic target	53
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung cancer: KEYNOTE‐042 China St	52
muTarget: A platform linking gene expression changes and mutation status in solid tumors	52
The potential of breast cancer screening in Europe	52
Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced es	51
GSDME and its role in cancer: From behind the scenes to the front of the stage	51
Vulvar intraepithelial neoplasia: Incidence and long‐term risk of vulvar squamous cell carcinoma	50
The European response to the WHO call to eliminate cervical cancer as a public health problem	50
Cervical cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index: A population‐based registry study	49
Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II	48
Histone lysine demethylases and their functions in cancer	46
Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study	45
Global patterns in testicular cancer incidence and mortality in 2020	45
Cost of decentralized CAR T‐cell production in an academic nonprofit setting	45
A demonstration of automated visual evaluation of cervical images taken with a smartphone camera	45
S100 calcium‐binding protein A9 from tumor‐associated macrophage enhances cancer stem cell‐like properties of hepatocellular carcinoma	45